The FDA, recognizing this issue, has prioritized reviewing generic applications for drugs in short supply, as seen with its recent approval of exenatide (Byetta) by Amneal Pharmaceuticals and Tevas earlier launch of an authorized generic version of Victoza in the U.S
The ultra-long half-life raises a potential concern: if adverse effects occur, they may take longer to resolve after discontinuation compared to shorter-acting agents
Vleugels, J
Administer subcutaneously with site rotation
Cambridge University Press, New York, pp 97161 Walker R, Lupien JR
Among BD patients with elevated levels of the inflammatory marker IL-6, there were increases in Lactobacillales and Streptococcaceae , suggesting a connection between inflammation and gut microbiota changes